AsianScientist (Oct. 28, 2016) – WuXi AppTec, a pharmaceutical, biotechnology, and medical device technology platform company, has received the inaugural Company of the Year Award from BayHelix. The award is part of the BayHelix China Healthcare Awards series, celebrating outstanding individuals and companies for their achievement and contribution to the China healthcare ecosystem.
BayHelix is an organization of leaders of Chinese heritage in the global life sciences and healthcare community. The China Healthcare Awards is presented in five categories: R&D Achievement of Year, Deal of the Year, Commercial Achievement of the Year, Company of the Year, and Person of the Year.
WuXi was recognized for its industry leadership, consistent achievements, and global impact. BayHelix also cited WuXi’s contributions to its partners, patients and society with a number of big strides, including platform capability enhancement to better enable its customers, innovative collaboration models to bring better medicines faster to China, and strategic initiatives to embrace the future of health.
———
Source: WuXi Apptec.
Disclaimer: This article does not necessarily reflect the views of AsianScientist or its staff.
